Provenge (sipuleucel-T)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Provenge (sipuleucel-T), covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 1]